Healthcare

passed · Maryland · House of Delegates Apr 13, 2026

HB 1426: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

HB 1426 creates a new permit for clinical research pharmacies in Maryland, which are facilities specifically designed to conduct clinical trials. It allows healthcare providers to own these pharmacies under strict conditions, including requiring a licensed pharmacist to be on-site during all operating hours and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations or entities from being classified as "practice of medicine," meaning trial staff no longer need individual medical licenses for their trial-related work. This change aims to streamline clinical research by removing a regulatory barrier that previously required individual licensing for trial staff.

Topics ✓ HealthcareSupports HealthcareEnables clinical trials via new pharmacy permits, promoting medical research and patient access to innovative treatments without restricting coverage.90% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed both · Maryland · House of Delegates Apr 13, 2026

HB 222: County Boards of Education - Opioid Overdose-Reversing Medications - Policy Requirements (Naloxone Access Act)

HB 222 requires Maryland public schools and colleges to update policies and education programs to address opioid overdoses. It mandates schools to store naloxone, allow authorized staff and students to possess it, and provide liability protection for good-faith use during overdoses. The bill also adds naloxone's life-saving role to K-12 drug prevention curricula (starting in third grade) and requires annual parent notifications about school naloxone policies. Additionally, schools must report overdose incidents requiring naloxone use to the State Department. This affects all public K-12 schools and state-funded colleges.

Topics ✓ EducationSupports EducationMandates inclusion of naloxone education in K-12 curricula (starting 3rd grade) and updates school policies, enhancing health education programs within educational framework.90% confidence ✓ HealthcareSupports HealthcareMandates naloxone access in schools for opioid overdose response, enhancing public health access and life-saving measures95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed both · Maryland · House of Delegates Apr 13, 2026

HB 417: Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

HB 417 (Public Health - Medetomidine and Xylazine Consumer Protection Act) regulates the sale of veterinary drugs medetomidine and xylazine. It prohibits retailers from selling these products without proof the buyer intends to use them for veterinary, scientific, or institutional purposes, and bans sales to anyone under 21. Retailers must maintain records of sales, including age verification and proof of intended use. Violations carry civil fines up to $6,500 per offense, with penalties deposited into Maryland's Substance Abuse Fund. The bill directly affects pharmacies, veterinary suppliers, and online retailers selling these specific products.

Topics ✓ Criminal JusticeSupports Criminal JusticeBill regulates sale of veterinary drugs used in fentanyl/xylazine mixtures, aiming to reduce drug availability and harm, supporting public safety and criminal justice reform efforts.75% confidence ✓ HealthcareSupports HealthcareRegulates veterinary drug sales to prevent human misuse, directly protecting public health through consumer safety measures under the bill's title and summary.90% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · Maryland · House of Delegates Apr 13, 2026

HB 633: Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage

HB 633 requires Maryland health insurers, nonprofit health plans, and health maintenance organizations to cover salpingectomy (surgical removal of fallopian tubes) as a preventive measure for ovarian cancer. It prohibits these insurers from charging copayments, coinsurance, or deductibles for this specific procedure, ensuring no out-of-pocket costs for covered individuals. The exception applies only to high-deductible health plans under federal law, allowing the deductible to apply to the procedure in those cases. This law directly affects women eligible for preventive care and the health insurance providers operating in Maryland.

Topics ✓ HealthcareSupports HealthcareMandates full insurance coverage for ovarian cancer prevention salpingectomy, prohibiting cost-sharing to improve access and patient rights.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed both · Maryland · Senate Apr 13, 2026

SB 489: Health Occupations - Physicians Trained in Foreign Countries - Exemption From Educational Requirements and Limited License

SB 489 modifies Maryland's licensing rules for physicians trained at international medical schools. It exempts applicants who provide evidence of completing two years of postgraduate training accredited by ACGME-I or another board-recognized body from standard educational requirements. These physicians would be permitted to practice medicine only during their initial license term under mandatory supervision, as specified by the Board. The bill takes effect October 1, 2026, directly affecting international medical graduates meeting these specific training criteria.

Topics ✓ HealthcareSupports HealthcareExempts international medical graduates from standard licensing requirements, enabling supervised practice to expand physician access and address healthcare workforce shortages.92% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · Maryland · House of Delegates Apr 10, 2026

HB 1167: Department of Information Technology - Workgroup on the Medicaid Management Information System Mainframe System Replacement

HB 1167 requires Maryland's Department of Health to replace its outdated Medicaid computer system with a modern, flexible system by 2028. The new system must maintain all current Medicaid functions - including processing medical/dental/pharmacy claims, provider enrollment, and beneficiary inquiries - while meeting federal security and performance standards. The bill mandates integration with existing Medicaid systems by January 2027 and full replacement of the old system by January 2028, subject to federal approval. This change directly affects Medicaid beneficiaries and healthcare providers through more reliable service delivery.

Topics ✓ HealthcareSupports HealthcareUpgrades Medicaid IT system to maintain coverage, ensure claim processing, and meet federal standards - directly supports healthcare service delivery and access.95% confidence ✓ TechnologySupports TechnologyRequires modern system meeting federal security standards, enhancing cybersecurity for Medicaid operations.90% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed both · Maryland · Senate Apr 10, 2026

SB 515: Health Services Cost Review Commission - Health Facilities - Rate Setting

SB 515 requires Maryland's Health Services Cost Review Commission to consider all operational costs incurred by health facilities - including expenses for physicians and other providers without corresponding billing revenue - when setting hospital rates. This affects hospitals and health facilities operating under Maryland's all-payer model, as the Commission must now factor in full costs during rate reviews. The bill amends existing law to mandate that the Commission evaluate facility financial health and certify rates based on complete cost accounting, rather than excluding certain expenses. This change ensures rates more accurately reflect actual facility operations, including costs for professional services that previously weren't fully counted.

Topics ✓ HealthcareSupports HealthcareMandates Commission to include all operational costs (including physician expenses) in hospital rate setting, ensuring facilities cover full costs without service reductions, strengthening sustainable healthcare funding under Maryland's all-payer ...85% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · Maryland · House of Delegates Apr 9, 2026

HB 1014: Mental Health Law - Danger to the Life or Safety of the Individual or of Others - Definition (Right to Treatment)

HB 1014 defines "danger to the life or safety of the individual or of others" for Maryland's mental health law, directly affecting individuals with mental disorders who might face involuntary admission. It specifies four concrete scenarios that constitute this danger: causing bodily harm, engaging in conduct leading to criminal involvement, inability to meet basic needs (food, shelter, medical care), or substantial deterioration in judgment that impairs treatment decisions. The definition requires a "substantial risk" considering the person's current condition and available history, replacing the prior standard. This change clarifies the legal threshold for involuntary hospitalization and emergency evaluations under Maryland law.

Topics ✓ HealthcareSupports HealthcareDefines clear criteria for involuntary mental health admission, preventing arbitrary detention and protecting patient rights under mental health law.85% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · Maryland · House of Delegates Mar 24, 2026

HB 860: Petitions for Emergency Evaluation (Arnaud and Magruder Memorial Act)

HB 860, the Arnaud and Magruder Memorial Act, sets a 5-day initial limit for emergency evaluation petitions after court approval, with extensions of up to 5 days each (totaling no more than 30 days) based on the individual's current behavior. The bill requires courts to include the petition's expiration date and clarifies that peace officers must transport individuals to emergency facilities when holding a valid petition (either court-endorsed within 5 days or signed by authorized professionals), allowing electronic petitions. This law directly affects courts reviewing petitions, peace officers executing them, emergency facilities receiving individuals, and people subject to emergency evaluations. It standardizes timelines and procedures to ensure timely care while preventing prolonged detention without court review.

Topics ✓ HealthcareSupports HealthcareMandates transport to emergency facilities for valid petitions, improving access to mental health evaluations under emergency protocols.85% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · Maryland · House of Delegates Mar 23, 2026

HB 1325: Workers' Compensation - Evaluation of Permanent Impairments - Licensed Social Worker-Clinical

HB 1325 authorizes licensed clinical social workers to evaluate permanent impairments involving behavioral or mental disorders in Maryland workers' compensation claims. It requires these social workers to meet specific qualifications, including training in mental/behavioral conditions, rehabilitation counseling registration, two years of post-licensure experience, and COMAR authorization. The bill directly affects workers seeking compensation for mental/behavioral impairments and licensed clinical social workers who wish to provide these evaluations. It amends Maryland’s workers’ compensation law (Article 9, Section 9-721) to expand evaluation eligibility beyond psychologists and physicians. The changes take effect October 1, 2026.

Topics ✓ HealthcareSupports HealthcareAuthorizes licensed clinical social workers to evaluate mental/behavioral impairments in workers' comp, expanding access to mental health assessments within healthcare framework.90% confidence ✓ Labor & EmploymentSupports Labor & EmploymentAuthorizes clinical social workers to evaluate mental/behavioral impairments in workers' comp claims, expanding access to benefits for affected workers.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track